AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

MedLife S.A.

Earnings Release Feb 28, 2025

2292_iss_2025-02-28_5ba35b65-093f-43b6-9988-061bbb2cfab4.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

To: BUCHAREST STOCK EXCHANGE FINANCIAL SUPERVISORY AUTHORITY

ANNOUNCEMENT

Current report drafted according to the stipulations of ASF Regulation no. 5/2018 on issuers of financial instruments and market operations, Law no. 24/2017 on issuers of financial instruments and market operations, and the provisions of Article 99 of the Bucharest Stock Exchange Code, Title II, Issuers and Financial Instruments

Report Date: 28 February 2025 Name of the issuing company: MED LIFE S.A. ("MedLife" or "the Company") Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania Telephone / Fax number: 0374 180 470 Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J40/3709/1996 Subscribed and paid-in share capital: 132,870,492 RON Total number of shares: 531,481,968 (out of which 427,042 shares without voting rights and 531,054,926 shares with voting rights) Regulated market on which the issued securities are traded: Bucharest Stock Exchange, Premium Category

Significant events to report: Correction of reporting preliminary results 2024

MED LIFE S.A. informs investors about the correction of some errors that occurred in the reporting of the preliminary financial results for the year 2024. Thus, the values for the year 2024 were presented as being for the year 2023 and vice versa, in the table regarding the Main Operational Indicators in the Current Report no. 18 / 28 February 2025, and on page 15 of the Financial Report for the year 2024 of the MedLife Group (only in the Romanian version), regarding the presentation of the net result.

Business line Info 12 months ended
2023 2024
Clinics Revenue 831,236,066 1,022,354,056
Clinics Visits 3,834,062 4,334,340
Clinics Avg fee 216.8 235.9
Stomatology Revenue 121,778,348 125,518,088
Stomatology Visits 185,829 185,582
Stomatology Avg fee 655.3 676.3
Hospitals Revenue 480,454,826 661,486,735
Hospitals Patients 139,234 164,941
Hospitals Avg fee 3,450.7 4,010.5
Laboratories Revenue 230,656,316 295,352,374

Please find below the corrected information.

ED LIFE S.A.

Registered Office: Bucharest, Calea Grivitei, no. 365, district 1, Romania Unique Registration Code at the National Office of Trade Registry: 8422035 Order number on the Trade Registry: J40/3709/1996 Subscribed and paid-in share capital: 5,536,270.5 RON

Laboratories Analyses 7,424,270 8,776,222
Laboratories Avg fee 31.1 33.7
Corporate Revenue 259,493,546 296,968,035
Corporate Subscriptions 873,036 872,014
Corporate Avg fee 297.2 340.6
Pharmacies Revenue 60,709,968 69,239,459
Pharmacies Clients 468,896 478,055
Pharmacies Sales per client 129.5 144.8
Others Revenue 226,106,278 244,537,692

We re-attach to this report the report regarding the preliminary results for the year 2024.

Mihail Marcu Chief Executive Officer

______________

Talk to a Data Expert

Have a question? We'll get back to you promptly.